BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2549566)

  • 1. Unresectable non-oat cell carcinoma of the lung: definitive radiation therapy.
    Mantravadi RV; Gates JO; Crawford JN; Bajpai D; Trenkner JD; Jordan LN
    Radiology; 1989 Sep; 172(3):851-5. PubMed ID: 2549566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer.
    Arcangeli G; Righini R; Nervi C; Guerra A; Tirindelli D; Hopkins H; Looney W
    Cancer Treat Rep; 1985 Jan; 69(1):25-31. PubMed ID: 2981618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
    Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
    Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative radiation therapy in the management of lung cancer.
    Emami B; Kim T; Roper C; Simpson JR; Pilepich MV; Hederman MA
    Radiology; 1987 Jul; 164(1):251-3. PubMed ID: 3035607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Local efficiency of percutaneous radiotherapy in lung cancer. Analysis of 215 repeated bronchoscopies in relation to applied radiation dosage].
    Schwegler N; Vrh N; Kern T; Notter M; Frey M; Grossenbacher M; Hausmann M; Pfenninger T; Ragaz A; Schmid R; Siebenschein R; Keller R
    Strahlenther Onkol; 1996 Feb; 172(2):81-90. PubMed ID: 8669049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of postoperative irradiation for stage III lung cancer.
    Nishikawa K; Koga K; Shibata K; Wake N; Takeuchi M; Watanabe K
    Radiat Med; 1984; 2(2):143-7. PubMed ID: 6097948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose radiation therapy for inoperable non-small cell lung cancer without mediastinal involvement (clinical stage N0, N1).
    Hayakawa K; Mitsuhashi N; Furuta M; Saito Y; Nakayama Y; Katano S; Yamakawa M; Hashida I; Niibe
    Strahlenther Onkol; 1996 Sep; 172(9):489-95. PubMed ID: 8830811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of the radiation therapy of lung cancer with conventional and median dosage fractionation].
    Strashinin AI; Ivanova LV; Tereshchenko OI
    Med Radiol (Mosk); 1985 Aug; 30(8):22-4. PubMed ID: 4033385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.
    Perez CA; Pajak TF; Rubin P; Simpson JR; Mohiuddin M; Brady LW; Perez-Tamayo R; Rotman M
    Cancer; 1987 Jun; 59(11):1874-81. PubMed ID: 3032394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swedish lung cancer radiation study group: predictive value of histology for radiotherapy response in patients with non-small cell lung cancer.
    Holgersson G; Bergström S; Bergqvist M; Nyman J; Hoye E; Helsing M; Friesland S; Holgersson M; Birath E; Ekman S; Blystad T; Ewers SB; Mörth C; Löden B; Henriksson R
    Eur J Cancer; 2011 Nov; 47(16):2415-21. PubMed ID: 21726999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
    Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
    Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polychemoradiation treatment of non-small cell lung cancer].
    Linchenko IF; Danil'ian Vm
    Med Radiol (Mosk); 1985 Aug; 30(8):64-9. PubMed ID: 2993782
    [No Abstract]   [Full Text] [Related]  

  • 16. [Radiation therapy for non-small cell lung cancer with postoperative intrathoracic recurrence].
    Kono K; Murakami M; Sasaki R; Okamoto Y; Yodenn E; Kobayashi K; Kubo T; Sai H; Maetani Y; Kuroda Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jan; 58(1):18-24. PubMed ID: 9493429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin and etoposide before definitive radiation therapy for inoperable squamous carcinoma, adenocarcinoma, and large cell carcinoma of the lung: a phase I-II study of the Radiation Therapy Oncology Group.
    Cox JD; Samson MK; Herskovic AM; Abrams R; Koehler M
    Cancer Treat Rep; 1986 Oct; 70(10):1219-20. PubMed ID: 3019546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose rate intraluminal brachytherapy in the treatment of malignant airway obstructions.
    Petera J; Spásová I; Neumanová R; Skricková J; Salajka F; Hrazdírová A; Kaplanová J; Coupková H; Coupek P; Kucera M
    Neoplasma; 2001; 48(2):148-53. PubMed ID: 11478697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer.
    Ajlouni M; Chapman R; Kim JH
    Cancer J Sci Am; 1996; 2(6):314-20. PubMed ID: 9166551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of survival of patients with lung cancer between elderly (greater than or equal to 70) and younger (70 greater than) age groups.
    Kusumoto S; Koga K; Tsukino H; Nagamachi S; Nishikawa K; Watanabe K
    Jpn J Clin Oncol; 1986 Dec; 16(4):319-23. PubMed ID: 3025476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.